Microphthalmia-associated transcription factor
Microphthalmia-associated transcription factor | ||
---|---|---|
Properties of human protein | ||
Mass / length primary structure | 357 to 526 amino acids | |
Secondary to quaternary structure | Homo- / heterodimer | |
Cofactor | (TFE3, TFEB, TFEC) | |
Isoforms | 12 | |
Identifier | ||
Gene names | MITF CMM8, MI, WS2, WS2A, bHLHe32 | |
External IDs | ||
Orthologue | ||
human | House mouse | |
Entrez | 4286 | 17342 |
Ensemble | ENSG00000187098 | ENSMUSG00000035158 |
UniProt | O75030 | Q08874 |
Refseq (mRNA) | NM_000248 | NM_001113198 |
Refseq (protein) | NP_000239 | NP_001106669 |
Gene locus | Chr 3: 69.74 - 69.97 Mb | Chr 6: 97.81 - 98.02 Mb |
PubMed search | 4286 |
17342
|
MITF ( microphthalmia-associated transcription factor ) is a protein found in vertebrates that is encoded by MITF genes. It is the transcription factor associated with tyrosinase and TRP-1 . MITF binds to the DNA sequences 5'-CACGTG-3 'or 5'-CATGTG-3', the so-called E-box. Ten paralogous isoforms of MITF are known in humans , which are localized in different tissue types. MITF plays a vital role in the differentiation of multiple tissues. Mutations of the MITF - gene can result in various forms of leucism and spotting lead. In addition, malformations of the eyes occur. In humans, mutations in the MITF gene can cause Tietz syndrome or Waardenburg syndrome .
In addition, the MITF gene is activated in 10–16% of all cases in metastatic melanoma . The exact role of MITF in melanoma development and progression is still unclear.
Individual evidence
- ↑ UniProt O75030
- ↑ JN Dynek et al .: Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. In: Cancer Res 68, 2008, pp. 3124-3132. PMID 18451137